On a brisk Sunday morning in October, a normally quiet grassy area outside the Chemistry Laboratories on Penns campus was filled with shrill cries.
Can anyone help me?!
It burns!
I cant hear out of this ear!!
Dozens of emergency workers jogged purposefully in and out of the lab building, some carrying backboards, others checking medical records, and still others triaging distressed students.
The pleas for help and bustling emergency workers would have been cause for alarmhad they not been part of a simulation intended to provide training for the Medical Emergency Response Team (MERT), a student-run service organization that provides emergency medical services to the Penn community. Begun in 2006, MERT is on call from 5 p.m. to 7 a.m. weeknights and 24 hours on weekends, responding to needs in concert with the Division of Public Safety (DPS) and the Philadelphia Fire Department (PFD). MERT is also supported by the Undergraduate Assembly, the Fox Leadership Program, and Student Health Service.
The simulated mass casualty incident, which mimicked the fallout from a mock explosion and chemical fire in two laboratories, involved 42 student EMTs, 44 volunteer victims, as well as observers from DPS and PFD. Its just one way that MERT goes above and beyond to serve the campus community, says Joshua Glick, an assistant professor of emergency medicine at the Perelman School of Medicine, MERTs medical director, and a MERT alum.
These students have taken it upon themselves to have essentially a full-time job on top of being an undergraduate student, which is a tremendous amount of work, its a tremendous amount of energy, he says. Being a student undergoing a medical emergencywhich can be really scarytheres something comforting about seeing your peers responding to you and helping you.
An interest in medicine is what draws many members of MERT to participate. But becoming involved with MERT is not something Penn students do on a whim. To join requires an internal application process after which members who arent already licensed must obtain certification as an EMT, either externally or through a semester-long training course sponsored by the group.
Emily Kopp, a senior neuroscience and economics double major in the College of Arts and Sciences from Scarsdale, New York, who now serves as MERTs chief, took the course in the spring of her first year at Penn. Me and about 15 or 20 other freshmen and sophomores would spent eight hours every Saturday learning materials, practicing skills, she says. By the end of the semester we were ready to take our licensing exams.
Learning is a continual focus for MERT. Weekly general body meetings allow members to maintain and improve skills in particular areas. Additional formal training happens each August during New Student Orientation, helping the EMTs brush up on competencies, including how to navigate their MERT-issued bikes around campus with up to 30 pounds of emergency equipment attached. Once each semester they strive to hold a mass casualty simulation. And during shifts, crews debrief after each call.
We talk about what we did well, what we didnt do well, what we need to work on, lingering questions, sometimes difficult emotions, says Kopp.
These students have taken it upon themselves to have essentially a full-time job on top of being an undergraduate student, which is a tremendous amount of work, its a tremendous amount of energy. Joshua Glick, an assistant professor of emergency medicine at the Perelman School of Medicine and MERTs medical director
Each MERT EMT is required to commit to 24 hours on shift each month. But many commit far more time. Youll find members of the board or those who are are at higher clinical ranks, like a leader or crew chief, will be taking on 40, 50, 70, up to 100-plus hours a month, says MERT Captain Mariana Restrepo, a senior neuroscience major from Boca Raton, Florida. Its not easy balancing it all, but doing so offers excellent time management skillsgood practice for the future, she says. Id say 80 to 90% of us are involved in extra research, plus seeing our friends, keeping sane.
I think most of our friends wonder how we do it, adds Kopp. From the outside, its a lota lot of hours, a lot of late nights, 100% worthwhile.
The MERT response zone mirrors the DPS patrol area, spanning from 30th to 43rd streets and from Market Street to Baltimore Avenue. During the teams service hours, when an emergency call requiring medical response comes into DPS PennComm Operations Center, the student EMTs on duty are called into action.
Every time they respond they are responding with the Philadelphia Fire Department and with the Penn Police, who establish a safe scene and a perimeter around the scene, says Gene Janda, chief of fire and emergency services in DPS. MERT students then treat patients and prepare them to be transported to the hospital by the PFD.
Janda, who was involved in helping students launch MERT 15 years ago, has seen the benefits of having this campus-based squad. Years ago, he recalls a student member on their way to chemistry class who helped deliver a baby. Another time, a crew assisted a student who fell through an attic floor and required careful handling to avoid further injury before being transported to the hospital.
It could be any situation, he says. It could be some type of trauma, or cardiac arrest; theyre trained for it.
Though MERT began purely as an emergency response service, the organization has since expanded in how it supports the Penn community. Beyond their shift work, MERT members now also coordinate training workshops for Penn faculty, staff, and students in CPR, first aid, stop the bleed injury response, and Narcan administration for opioid overdoses. Many members also do work in the community to promote health and safety.
Kopp, whose role entails coordinating MERTs activities with that of other partners, DPS primary among them, says that the organization works seamlessly with DPS and PFD first responders.
We are all able to work as a team and make sure this campus is really prepared for anything, Kopp says.
Each EMT that is part of MERT could easily point to numerous occasions when their emergency response training was put into meaningful action. For Restrepo, a particularly powerful memory is of administering Narcan to a person in the West Philadelphia community. I walked away from that call, that patient, knowing I saved his life, she says. I think that was the first time I saw the direct impact of our role. We are in the community to save lives.
Restrepo is now in the midst of applying to medical school. And Kopp, too, plans to attend, as do many MERT members. Glick offers living proof of how service with MERT can translate to a career in medicine.
I hit the ground running in medical school, Glick says, who often tells MERT students that the organization equips them with three intangible qualities: a sense of teamwork, great communication skills, and adaptability. Always being comfortable in the uncomfortable, he says, is a skill helpful both in medicine and in life.
I think most of our friends wonder how we do it. From the outside, its a lota lot of hours, a lot of late nights, 100% worthwhile. Senior Emily Kopp, MERTs chief
That embrace of on-the-fly learning was on full display at the mass casualty training event earlier this fall. As MERT team members triaged volunteer patients complaining of head trauma and burn woundsand one even acting out a mental health emergencythey contended with challenges they hadnt anticipated. Despite moment of hesitation and uncertainty, the MERT students eventually ensured that all victims were evacuated from the labs, effectively triaged, and, where needed, transported to the hospital (or back to a dining hall for late-morning bagels and coffee).
To bring the simulation to a close, Lilian Zhang, MERTs disaster response team officer, radioed to her peers, The drill is now completed. But the morningand the learningwasnt quite over. MERT team members filed into the Chemistry building auditorium for a hotwash, a postmortem evaluation of their performance where DPS and other observers offered constructive feedback.
A major takeaway, according to James Taylor, a paramedic and 26 year veteran of the PFD? MERT members took on the simulations challenges with energy, zeal, and readiness. They got the job done.
Learn more on the MERT website.
View allsimulated mass casualty incident photos on Flickr.
Read the original:
Penn's Medical Emergency Response Team, 'prepared for anything' | Penn Today - Penn Today
- BENITEC BIOPHARMA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com - February 13th, 2023 [February 13th, 2023]
- CENTOGENE to Participate in Upcoming Conferences in February in the Lead Up to Rare Disease Day - Marketscreener.com - February 7th, 2023 [February 7th, 2023]
- Gene | Definition, Structure, Expression, & Facts | Britannica - January 27th, 2023 [January 27th, 2023]
- New gene therapy delivers treatment directly to brain - January 27th, 2023 [January 27th, 2023]
- Indian Pharma Congress: Gene-cell therapy, preventive medicine future of health care, says expert - Economic Times - January 25th, 2023 [January 25th, 2023]
- A blood test that identifies people at higher risk of miscarriage? Thats the goal of this award-winning Rutgers med student. - The Philadelphia... - January 19th, 2023 [January 19th, 2023]
- Gene Therapy: Genes As Medicine | Pfizer - January 6th, 2023 [January 6th, 2023]
- How Genomics will ensure a risk-free and beneficial treatment for good health and well-being - The Financial Express - December 28th, 2022 [December 28th, 2022]
- Regenerative Medicine Advanced Therapy Designation | FDA - December 18th, 2022 [December 18th, 2022]
- 3576 - Gene ResultCXCL8 C-X-C motif chemokine ligand 8 [ (human)] - November 23rd, 2022 [November 23rd, 2022]
- Study identifies new gene that drives colon cancer - EurekAlert - October 17th, 2022 [October 17th, 2022]
- Updated Stroke Gene Panels: Rapid evolution of knowledge on monogenic causes of stroke | European Journal of Human Genetics - Nature.com - October 17th, 2022 [October 17th, 2022]
- The challenges of translating CRISPR to the clinic - Labiotech.eu - October 17th, 2022 [October 17th, 2022]
- Editas Medicine Presents Preclinical Data on EDIT-103 for Rhodopsin-associated Autosomal Dominant Retinitis Pigmentosa at the European Society of Gene... - October 17th, 2022 [October 17th, 2022]
- 'We have to find a way': FDA seeks solutions to aid bespoke gene therapy - BioPharma Dive - October 17th, 2022 [October 17th, 2022]
- Mathematical model could bring us closer to effective stem cell therapies - Michigan Medicine - October 17th, 2022 [October 17th, 2022]
- Approval, Commercialization Highlighted at Cell & Gene Meeting on the Mesa - Genetic Engineering & Biotechnology News - October 17th, 2022 [October 17th, 2022]
- CANbridge-UMass Chan Medical School Gene Therapy Research in Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 29th Annual... - October 17th, 2022 [October 17th, 2022]
- Depression Treatment: How Genetic Testing Can Help Find the Right Medication - Dunya News - October 17th, 2022 [October 17th, 2022]
- The Risk-Reward Proposition for CGT Clinical Trials - Applied Clinical Trials Online - October 17th, 2022 [October 17th, 2022]
- Precision Medicine Could Get Even More Precise With Allarity Therapeutics Next-Generation Diagnostics - Benzinga - October 17th, 2022 [October 17th, 2022]
- Decibel Therapeutics Receives FDA Clearance of IND Application for DB-OTO, a Gene Therapy Product Candidate Designed to Provide Hearing to Individuals... - October 17th, 2022 [October 17th, 2022]
- Time for your medicine: unlocking the power of our body clocks - The Guardian - October 17th, 2022 [October 17th, 2022]
- Replay establishes distinguished Scientific Advisory Board of genomic medicine and cell therapy experts - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- Scientists Reappraise the Role of Zombie Cells That Anti-aging Medicine Has Sought to Eliminate - Neuroscience News - October 17th, 2022 [October 17th, 2022]
- Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease - Business... - October 17th, 2022 [October 17th, 2022]
- Gene Expression Signatures Are Analyzed for Biomarkers of Response in HCC - Targeted Oncology - October 17th, 2022 [October 17th, 2022]
- NHS England World-first national genetic testing service to deliver rapid life-saving checks for babies and kids - NHS England - October 17th, 2022 [October 17th, 2022]
- The proteinprotein relationship that could mend a broken heart - RegMedNet - October 17th, 2022 [October 17th, 2022]
- Study finds microprotein correlated to Alzheimers risk - Daily Trojan Online - October 11th, 2022 [October 11th, 2022]
- Passage Bio Announces Appointment of William Chou, M.D. as Chief Executive Officer - Yahoo Finance - October 11th, 2022 [October 11th, 2022]
- Gene Therapy Rapidly Improves Night Vision in Adults with Congenital Blindness - Newswise - October 11th, 2022 [October 11th, 2022]
- Scientists Discover Protein Partners that Could Heal Heart Muscle | Newsroom - UNC Health and UNC School of Medicine - October 11th, 2022 [October 11th, 2022]
- The Pros and Cons of Lentiviral and Adeno-Associated Viral Vectors - The Medicine Maker - October 11th, 2022 [October 11th, 2022]
- Insights & Outcomes: Foreign DNA, quantum potholes and relapsing fever - Yale News - October 11th, 2022 [October 11th, 2022]
- Expediting IND applications with drug master files - BioPharma Dive - October 11th, 2022 [October 11th, 2022]
- UNC School of Medicine Awarded $3 Million to Lead Study to Reduce PTSD Frequency, Severity | Newsroom - UNC Health and UNC School of Medicine - October 11th, 2022 [October 11th, 2022]
- Lineage to Present at Alliance for Regenerative Medicine 2022 Cell & Gene Meeting on the Mesa - businesswire.com - October 8th, 2022 [October 8th, 2022]
- The Next Crispr Gene Editing IPO Could Be Near - Henry Herald - October 8th, 2022 [October 8th, 2022]
- 10-year CRISPR anniversary: How gene editing revolutionized medicine, and what lies ahead - Genetic Literacy Project - October 8th, 2022 [October 8th, 2022]
- Blood from a baby at birth can be gene sequenced to prevent diseases - USA TODAY - October 8th, 2022 [October 8th, 2022]
- What doctors wish patients knew about breast-cancer prevention - American Medical Association - October 8th, 2022 [October 8th, 2022]
- Growth in Cell and Gene Therapy Market - Pharmaceutical Technology Magazine - October 8th, 2022 [October 8th, 2022]
- Gene Editing Service Market 2022 : Top Players to Reflect Impressive Growth Rate till 2029: Caribou Biosciences, CRISPR Therapeutics, Merck KGaA,... - October 8th, 2022 [October 8th, 2022]
- Tip Sheet: $78 million to support new precision oncology institute, update on experimental gene therapy for herpes and the launch of Fred Hutch's new... - October 8th, 2022 [October 8th, 2022]
- Cell and Gene Therapy: Rewriting the Future of Medicine - Technology Networks - October 2nd, 2022 [October 2nd, 2022]
- Growth in Cell and Gene Therapy Market - BioPharm International - October 2nd, 2022 [October 2nd, 2022]
- CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX130 for the Treatment of Cutaneous T-Cell... - October 2nd, 2022 [October 2nd, 2022]
- BioMarin Resubmits Biologics License Application (BLA) for Valoctocogene Roxaparvovec AAV Gene Therapy for Severe Hemophilia A to the FDA - PR... - October 2nd, 2022 [October 2nd, 2022]
- Fighting Breast and Ovarian Cancer With a Lupus Antibody - Yale School of Medicine - October 2nd, 2022 [October 2nd, 2022]
- This gene therapy company is testing new tech to 'switch off' diabetes and obesity with a pill - Euronews - October 2nd, 2022 [October 2nd, 2022]
- Tenaya Therapeutics to Participate in Inaugural Hypertrophic Cardiomyopathy Medical Societys 2022 Scientific Sessions - Yahoo Finance - October 2nd, 2022 [October 2nd, 2022]
- Risk of Alzheimer's dementia may be predicted with help of new tool Washington University School of Medicine in St. Louis - Washington University... - October 2nd, 2022 [October 2nd, 2022]
- Tiny Sea Creature's Genes Shed Light on Evolution of Immunity - UPMC - October 2nd, 2022 [October 2nd, 2022]
- Who will get the call from Stockholm? It's time for STAT's 2022 Nobel Prize predictions - STAT - October 2nd, 2022 [October 2nd, 2022]
- Excision BioTherapeutics Awarded California Institute for Regenerative Medicine (CIRM) Grant to Support Ongoing Phase 1/2 Trial Evaluating EBT-101 as... - October 2nd, 2022 [October 2nd, 2022]
- NeuroVoices: Emma Ciafaloni, MD, on the Vast Expansion of Innovative Approaches to Duchenne Muscular Dystrophy - Neurology Live - October 2nd, 2022 [October 2nd, 2022]
- COVID mRNA Jabs and Testing Kicked Off This Industry of Drug Development: Here's What You Need to Know - The Epoch Times - October 2nd, 2022 [October 2nd, 2022]
- Kidney resident macrophages have distinct subpopulations and occupy distinct microenvironments - University of Alabama at Birmingham - October 2nd, 2022 [October 2nd, 2022]
- Nobel Prize for medicine: the full list of winners - The National - October 2nd, 2022 [October 2nd, 2022]
- The surprising link between circadian disruption and cancer may have to do with temperature - EurekAlert - October 2nd, 2022 [October 2nd, 2022]
- The global live cell imaging market is expected to grow at a CAGR of 8.44% during 2022-2027 - Yahoo Finance - October 2nd, 2022 [October 2nd, 2022]
- Chroma Medicine Announces Formation of Scientific Advisory Board of Global Experts in Gene Editing and Cell and Gene Therapy - PR Newswire - September 20th, 2022 [September 20th, 2022]
- Ring Therapeutics Announces Issuance of U.S. Patent for its Anellovector Compositions - Yahoo Finance - September 20th, 2022 [September 20th, 2022]
- Cholesterol gene mutation: Why would a healthy 27-year-old have severe heart problems? - 69News WFMZ-TV - September 20th, 2022 [September 20th, 2022]
- Gene Therapy for Severe Hemophilia B Could Be More Cost Effective Than Current Treatments - Managed Healthcare Executive - September 20th, 2022 [September 20th, 2022]
- AVROBIO Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration (FDA) for First Gene Therapy in Development for Cystinosis... - September 20th, 2022 [September 20th, 2022]
- The Biggest CGT Breakthroughs Through the Eyes of Our 2022 Power List - The Medicine Maker - September 20th, 2022 [September 20th, 2022]
- Leading Virus Researcher to Chair UVA's Department of Microbiology, Immunology and Cancer Biology - UVA Health Newsroom - September 20th, 2022 [September 20th, 2022]
- Work remains on Tay-Sachs and other Ashkenazi genetic disorders J. - The Jewish News of Northern California - September 20th, 2022 [September 20th, 2022]
- Study Shows Genetic Link to Moving to the Beat of Music - Newswise - September 20th, 2022 [September 20th, 2022]
- Viewpoint: In the post Roe v Wade world, what changes should a biology textbook writer make to address the medical repercussions of Dobbs? - Genetic... - September 20th, 2022 [September 20th, 2022]
- Alnylam Receives Approval in Europe for AMVUTTRA (vutrisiran) for the Treatment of Hereditary Transthyretin-mediated (hATTR) Amyloidosis in Adult... - September 20th, 2022 [September 20th, 2022]
- CSL flexes gene therapy muscle with latest drug - Sydney Morning Herald - September 20th, 2022 [September 20th, 2022]
- The MIT Press releases new book on the science of the heart from cardiac expert Dr. Sian Harding - EurekAlert - September 20th, 2022 [September 20th, 2022]
- Global Pharmaceutical Contract Manufacturing Market is projected to reach a market value of US$329.7 Billion in 2032: Visiongain Reports Ltd - Yahoo... - September 20th, 2022 [September 20th, 2022]
- Alzheon Reports Industry-Leading Biomarker, Brain Preservation and Clinical Effects Following 12 Months of Treatment in Phase 2 Trial of Oral ALZ-801... - September 20th, 2022 [September 20th, 2022]
- Do You Have Lung Cancer With An EGFR Mutation? If So, The Drug Tagrisso Might Be Right For You Based On New Results From A 'Practice Changing' Trial -... - September 20th, 2022 [September 20th, 2022]
- Getting rid of unwanted transformed cells: Possible new directions in cancer therapy - EurekAlert - September 20th, 2022 [September 20th, 2022]
- Sven Kili on reconvening with the ISCT - The Medicine Maker - September 14th, 2022 [September 14th, 2022]